CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 87.41% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Scan to Download iOS&Android APP

Trade Guardion Health Sciences, Inc. - GHSI CFD

0.1625
0.25%
0.0164
Low: 0.1574
High: 0.1721
Market Trading Hours* (UTC) Opens on Wednesday at 14:30

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0164
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0308%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.0308 %
Charges from borrowed part ($-1.23)
Trade size with leverage ~ $5,000.00
Money from leverage ~ $4,000.00

Go to platform
-0.0137%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 20%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Key Stats
Prev. Close* 0.1621
Open* 0.1721
1-Year Change* 7.83%
Day's Range* 0.1574 - 0.1574
52 wk Range 0.13-1.14
Average Volume (10 days) 0.61725
Average Volume (3 months) 28.8194
Market Cap 9.48653
P/E Ratio N/A
Shares Outstanding 61600800
Revenue 10.9509
EPS -0.71436
Dividend (Yield %) N/A
Beta 0.83244
Next Earnings Date Mar 30, 2023

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 5, 2022 0.1621 0.0064 4.11% 0.1557 0.1677 0.1557
Dec 2, 2022 0.1618 0.0013 0.81% 0.1605 0.1629 0.1604
Dec 1, 2022 0.1596 -0.0028 -1.72% 0.1624 0.1716 0.1552
Nov 30, 2022 0.1644 0.0099 6.41% 0.1545 0.1714 0.1458
Nov 29, 2022 0.1652 0.0038 2.35% 0.1614 0.1677 0.1575
Nov 28, 2022 0.1664 0.0165 11.01% 0.1499 0.1677 0.1432
Nov 25, 2022 0.1504 0.0025 1.69% 0.1479 0.1531 0.1450
Nov 23, 2022 0.1510 0.0080 5.59% 0.1430 0.1529 0.1430
Nov 22, 2022 0.1468 0.0150 11.38% 0.1318 0.1517 0.1318
Nov 21, 2022 0.1386 -0.0016 -1.14% 0.1402 0.1402 0.1290
Nov 18, 2022 0.1386 -0.0031 -2.19% 0.1417 0.1419 0.1356
Nov 17, 2022 0.1386 0.0000 0.00% 0.1386 0.1410 0.1351
Nov 16, 2022 0.1395 -0.0087 -5.87% 0.1482 0.1482 0.1385
Nov 15, 2022 0.1435 0.0001 0.07% 0.1434 0.1462 0.1417
Nov 14, 2022 0.1443 -0.0181 -11.15% 0.1624 0.1624 0.1431
Nov 11, 2022 0.1593 0.0035 2.25% 0.1558 0.1624 0.1503
Nov 10, 2022 0.1558 0.0040 2.64% 0.1518 0.1597 0.1503
Nov 9, 2022 0.1520 -0.0055 -3.49% 0.1575 0.1612 0.1502
Nov 8, 2022 0.1589 -0.0022 -1.37% 0.1611 0.1655 0.1585
Nov 7, 2022 0.1601 -0.0032 -1.96% 0.1633 0.1633 0.1590

Guardion Health Sciences, Inc. Events

Time (UTC) Country Event
No events scheduled
View all events
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total revenue 0.14103 0.43735 0.94215 0.90294 1.88984 7.23312
Revenue 0.14103 0.43735 0.94215 0.90294 1.88984 7.23312
Cost of Revenue, Total 0.0757 0.17547 0.39818 0.34132 1.3307 4.12268
Gross Profit 0.06533 0.26188 0.54397 0.56162 0.55914 3.11044
Total Operating Expense 4.08672 5.71879 7.08587 11.3999 10.4416 31.9799
Selling/General/Admin. Expenses, Total 3.66462 5.24827 6.19334 9.26249 8.87082 13.476
Research & Development 0.03654 0.22989 0.19732 0.16131 0.12513 0.02625
Depreciation / Amortization 0.06013 0.06516 0.29704 0.07124 0.06548 0.09158
Unusual Expense (Income) 0.24974 0 1.56352 0.04945 14.2634
Operating Income -3.94569 -5.28144 -6.14372 -10.4969 -8.55174 -24.7468
Interest Income (Expense), Net Non-Operating -1.10456 -0.02373 -1.62369 0.03458 -0.01993 0.0018
Other, Net -0.69815 0 -0.41596 0
Net Income Before Taxes -5.7484 -5.30517 -7.76741 -10.8783 -8.57166 -24.745
Net Income After Taxes -5.7484 -5.30517 -7.76741 -10.8783 -8.57166 -24.745
Net Income Before Extra. Items -5.7484 -5.30517 -7.76741 -10.8783 -8.57166 -24.745
Net Income -5.7484 -5.30517 -7.76741 -10.8783 -8.57166 -24.745
Total Adjustments to Net Income -0.79503 -0.91058 0
Income Available to Common Excl. Extra. Items -6.54343 -6.21575 -7.76741 -10.8783 -8.57166 -24.745
Income Available to Common Incl. Extra. Items -6.54343 -6.21575 -7.76741 -10.8783 -8.57166 -24.745
Diluted Net Income -6.54343 -6.21575 -7.76741 -10.8783 -8.57166 -24.745
Diluted Weighted Average Shares 3.63353 4.64482 3.36484 6.07814 14.2569 23.6886
Diluted EPS Excluding Extraordinary Items -1.80085 -1.33821 -2.3084 -1.78974 -0.60123 -1.04459
Dividends per Share - Common Stock Primary Issue 0
Diluted Normalized EPS -1.73212 -1.33821 -2.3084 -1.53251 -0.59776 -0.44247
Q1 2021 Q2 2021 Q3 2021 Q4 2021 Q1 2022
Total revenue 0.2333 1.22372 3.14861 2.62749 2.38462
Revenue 0.2333 1.22372 3.14861 2.62749 2.38462
Cost of Revenue, Total 0.13302 0.66522 1.76059 1.56384 1.28816
Gross Profit 0.10028 0.5585 1.38802 1.06365 1.09646
Total Operating Expense 2.90282 5.76427 6.16413 17.1487 5.00467
Selling/General/Admin. Expenses, Total 2.7492 2.97862 4.07525 3.72642 3.68556
Research & Development 0.02061 0.01676 0.01623 0.01076 0.00669
Operating Income -2.66952 -4.54055 -3.01552 -14.5212 -2.62005
Interest Income (Expense), Net Non-Operating 0 0.00027 0.00068 0.00086 0.00156
Net Income Before Taxes -2.66953 -4.54029 -3.01484 -14.5204 -2.61849
Net Income After Taxes -2.66953 -4.54029 -3.01484 -14.5204 -2.61849
Net Income Before Extra. Items -2.66953 -4.54029 -3.01484 -14.5204 -2.61849
Net Income -2.66953 -4.54029 -3.01484 -14.5204 -2.61849
Income Available to Common Excl. Extra. Items -2.66953 -4.54029 -3.01484 -14.5204 -2.61849
Income Available to Common Incl. Extra. Items -2.66953 -4.54029 -3.01484 -14.5204 -2.61849
Diluted Net Income -2.66953 -4.54029 -3.01484 -14.5204 -2.61849
Diluted Weighted Average Shares 21.3514 24.427 24.427 24.5153 39.1509
Diluted EPS Excluding Extraordinary Items -0.12503 -0.18587 -0.12342 -0.5923 -0.06688
Dividends per Share - Common Stock Primary Issue 0 0 0 0
Diluted Normalized EPS -0.12503 -0.09975 -0.11065 -0.10902 -0.06626
Unusual Expense (Income) 2.10368 0.31206 11.8477 0.02426
Other Operating Expenses, Total 0
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Total Current Assets 0.13756 5.0799 1.10492 11.8677 9.09488 12.0692
Cash and Short Term Investments 0.06252 4.73523 0.67095 11.1155 8.51873 9.08955
Cash 0.06252 4.73523 0.67095 11.1155 8.51873 4.09393
Total Receivables, Net 0.00167 0.07277 0.0282 0.07834 0.01125 1.41157
Accounts Receivable - Trade, Net 0.00167 0.07277 0.0282 0.07834 0.01125 1.41157
Total Inventory 0.044 0.15473 0.358 0.31094 0.38497 0.36769
Prepaid Expenses 0.02936 0.11716 0.04777 0.36294 0.17993 1.20038
Total Assets 0.26205 7.37022 3.6811 12.8768 9.8609 23.4606
Property/Plant/Equipment, Total - Net 0.11402 0.0956 0.2748 0.94735 0.70427 0.13564
Property/Plant/Equipment, Total - Gross 0.27718 0.27196
Accumulated Depreciation, Total -0.16316 -0.13633
Other Long Term Assets, Total 0.01047 0.01047 0.28175 0.01175 0.01175 0
Total Current Liabilities 0.60762 0.49995 0.49534 0.41023 1.07373 1.15905
Accounts Payable 0.35647 0.31124 0.41393 0.12913 0.60831 0.24135
Accrued Expenses 0.08829 0.01204 0.08141 0.26778 0.29048 0.9177
Notes Payable/Short Term Debt 0 0.03054 0 0 0 0
Current Port. of LT Debt/Capital Leases 0.07138 0
Other Current Liabilities, Total 0.09148 0.14613 0 0.01332 0.17494 0
Total Liabilities 0.60762 0.49995 0.49534 0.84498 1.34563 1.16285
Total Long Term Debt 0 0 0 0 0 0
Long Term Debt 0
Total Equity -0.34557 6.87028 3.18576 12.0318 8.51527 22.2978
Preferred Stock - Non Redeemable, Net 0.00171 0 0 0 0
Common Stock 0.02505 0.04018 0.02056 0.07498 0.01517 0.02443
Additional Paid-In Capital 20.2779 33.696 37.7986 57.4685 62.5834 101.075
Retained Earnings (Accumulated Deficit) -20.6502 -26.866 -34.6334 -45.5117 -54.0833 -78.8021
Total Liabilities & Shareholders’ Equity 0.26205 7.37022 3.6811 12.8768 9.8609 23.4606
Total Common Shares Outstanding 4.17449 6.69725 3.42739 12.4971 15.1706 24.427
Goodwill, Net 1.56352 1.56352 0
Intangibles, Net 0.62074 0.4561 0.05 0.05 11.2558
Other Liabilities, Total 0.43475 0.2719 0.00381
Short Term Investments 4.99562
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Total Current Assets 43.9956 16.5469 14.8666 12.0692 20.568
Cash and Short Term Investments 43.3297 12.5027 10.5587 9.08955 16.8296
Cash 43.3297 5.50241 3.56385 4.09393 4.83247
Total Receivables, Net 0.0649 1.88478 2.26862 1.41157 2.19839
Accounts Receivable - Trade, Net 0.0649 1.88478 2.26862 1.41157 2.19839
Total Inventory 0.28853 0.95626 0.79263 0.36769 0.82233
Prepaid Expenses 0.31252 1.20317 1.24671 1.20038 0.71763
Total Assets 44.7025 41.2848 38.6132 23.4606 31.6205
Property/Plant/Equipment, Total - Net 0.6451 0.58497 0.29879 0.13564 0.09423
Property/Plant/Equipment, Total - Gross 1.10614 1.06743 0.45973 0.27196 0.22405
Accumulated Depreciation, Total -0.46105 -0.48245 -0.16094 -0.13633 -0.12982
Intangibles, Net 0.05 11.8508 11.5533 11.2558 10.9583
Other Long Term Assets, Total 0.01175 0.31408 0.00128 0
Total Current Liabilities 0.98269 1.80496 1.97012 1.15905 1.82641
Accounts Payable 0.2304 0.76834 1.18296 0.24135 1.14637
Accrued Expenses 0.68458 1.03662 0.78717 0.9177 0.68004
Notes Payable/Short Term Debt 0 0 0 0 0
Other Current Liabilities, Total 0.06771 0 0 0
Total Liabilities 1.21212 1.99139 1.97012 1.16285 1.82641
Total Long Term Debt 0 0 0 0 0
Other Liabilities, Total 0.22943 0.18643 0 0.00381 0
Total Equity 43.4903 39.2934 36.6431 22.2978 29.7941
Preferred Stock - Non Redeemable, Net 0 0 0 0
Common Stock 0.02443 0.02443 0.02443 0.02443 0.06143
Additional Paid-In Capital 100.193 100.536 100.9 101.075 111.153
Retained Earnings (Accumulated Deficit) -56.7269 -61.2669 -64.2817 -78.8021 -81.4206
Total Liabilities & Shareholders’ Equity 44.7025 41.2848 38.6132 23.4606 31.6205
Total Common Shares Outstanding 24.427 24.427 24.427 24.427 61.427
Short Term Investments 7.00027 6.99481 4.99562 11.9971
Goodwill, Net 11.9881 11.8931
  • Annual
  • Quarterly
2016 2017 2018 2019 2020 2021
Net income/Starting Line -5.7484 -5.30517 -7.76741 -10.8783 -8.57166 -24.745
Cash From Operating Activities -1.65357 -3.4037 -4.17383 -6.03 -8.01393 -10.6444
Cash From Operating Activities 0.06013 0.11882 0.29567 0.47735 0.06548 0.78292
Non-Cash Items 3.91755 2.11532 3.21643 4.8027 0.79114 13.7546
Changes in Working Capital 0.11714 -0.33267 0.08147 -0.43174 -0.29889 -0.43689
Cash From Investing Activities -0.00335 -0.03239 -0.31024 -0.17108 -0.03473 -31.0114
Capital Expenditures -0.00335 -0.03728 -0.31024 -0.17108 -0.04073 -0.07459
Cash From Financing Activities 1.7056 8.10879 0.41979 16.6456 5.45189 37.231
Financing Cash Flow Items 0.2156 0.05465 -0.41613 0
Issuance (Retirement) of Stock, Net 1.145 8.105 0.86646 16.3962 5.45189 37.231
Issuance (Retirement) of Debt, Net 0.345 -0.05086 -0.03054 0.24945
Net Change in Cash 0.04867 4.67271 -4.06428 10.4445 -2.59677 -4.42481
Other Investing Cash Flow Items, Total 0.0049 0 0.006 -30.9368
Cash Taxes Paid 0 0 0 0
Cash Interest Paid 0 0 0.00727 0
Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022
Net income/Starting Line -2.66953 -7.20981 -10.2247 -24.745 -2.61849
Cash From Operating Activities -2.42007 -7.28535 -9.07817 -10.6444 -2.22647
Cash From Operating Activities 0.0197 0.14028 0.45778 0.78292 0.31705
Non-Cash Items 0.42709 0.81004 1.52679 13.7546 0.17013
Cash Taxes Paid 0.00936 0.02084 0.02084 0 0
Cash Interest Paid 0 0 0 0 0
Changes in Working Capital -0.19733 -1.02585 -0.8381 -0.43689 -0.09516
Cash From Investing Activities 0 -32.962 -33.1077 -31.0114 -7.00392
Capital Expenditures 0 -0.00114 -0.07681 -0.07459 -0.0024
Cash From Financing Activities 37.231 37.231 37.231 37.231 9.96894
Issuance (Retirement) of Stock, Net 37.231 37.231 37.231 37.231 9.96894
Net Change in Cash 34.8109 -3.01632 -4.95488 -4.42481 0.73854
Other Investing Cash Flow Items, Total -32.9608 -33.0309 -30.9368 -7.00152
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
Radoff (Bradley Louis) Individual Investor 7.6298 4700000 4700000 2022-11-21 LOW
Renaissance Technologies LLC Hedge Fund 2.7986 1723950 149200 2022-09-30 HIGH
Millennium Management LLC Hedge Fund 1.3261 816897 451114 2022-09-30 HIGH
Radoff Family Foundation Corporation 1.0065 620000 620000 2022-11-21 HIGH
BlackRock Institutional Trust Company, N.A. Investment Advisor 0.814 501454 0 2022-09-30 LOW
Scholtes (Bret D) Individual Investor 0.5392 332155 189846 2022-04-18
Susquehanna International Group, LLP Investment Advisor 0.4751 292640 272682 2022-09-30 MED
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 0.468 288281 -787758 2022-09-30 LOW
Evans (David W) Individual Investor 0.4179 257417 -2 2022-04-18
Barclays Capital Inc. Research Firm 0.4058 250000 0 2022-09-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 0.2758 169865 0 2022-09-30 LOW
UBS Financial Services, Inc. Investment Advisor 0.2477 152596 74679 2022-09-30 LOW
Ergoteles Capital Hedge Fund 0.2235 137705 137705 2022-09-30 HIGH
State Street Global Advisors (US) Investment Advisor/Hedge Fund 0.219 134934 0 2022-09-30 LOW
Weingarten (Robert Neal) Individual Investor 0.1928 118750 0 2022-04-18 LOW
Goldstone (Mark) Individual Investor 0.1421 87550 0 2022-04-18
Virtu Americas LLC Research Firm 0.1287 79277 -38717 2022-09-30 HIGH
Northern Trust Investments, Inc. Investment Advisor/Hedge Fund 0.0936 57649 32852 2022-09-30 LOW
Balyasny Asset Management LP Hedge Fund 0.0728 44856 44856 2022-09-30 HIGH
Tower Research Capital LLC Hedge Fund 0.0626 38574 -34628 2022-09-30 HIGH

Why choose Capital.com? Our numbers speak for themselves.

Capital.com Group
475000+

Traders

71000+

Active clients monthly

$51000000+

Monthly investing volume

$30000000+

Withdrawn each month

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
  • 2:1
  • 5:1
  • 10:1
  • 20:1
Leverage
20:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

Guardion Health Sciences, Inc. Company profile

Guardion Health Sciences, Inc., together with its subsidiaries, operates as a specialty health sciences company in the United States. It operates in two segments, Medical Foods and Nutraceuticals, and Medical Devices. The company offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma. It also provides MapcatSF, a medical device that measures the macular pigment optical density; CSV-1000 device that offers auto-calibrated tests to ensure the correct testing luminance and contrast levels; and CSV-2000, a digital standardized contrast sensitivity testing device, as well as develops, manufactures, and sells equipment and supplies for standardized vision testing under the VectorVision name for use by eye doctors in clinical trials, real-world vision evaluation, and industrial vision testing. In addition, the company develops ImmuneSF, a nutraceutical formulation, as well as a portfolio of nutraceutical products under the NutriGuard brand. Further, it distributes medical foods products through e-commerce in an online store, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in San Diego, California.
Industry: Pharmaceuticals (NEC)

2925 Richmond Avenue
Suite 1200
HOUSTON
TEXAS 77098
US

Income Statement

People also watch

Natural Gas

5.38 Price
-4.450% 1D Chg, %
Long position overnight fee 0.0411%
Short position overnight fee -0.0662%
Overnight fee time 22:00 (UTC)
Spread 0.005

US100

11,561.10 Price
-2.010% 1D Chg, %
Long position overnight fee -0.0172%
Short position overnight fee 0.0062%
Overnight fee time 22:00 (UTC)
Spread 1.8

Oil - Crude

74.80 Price
-3.650% 1D Chg, %
Long position overnight fee -0.0096%
Short position overnight fee -0.0057%
Overnight fee time 22:00 (UTC)
Spread 0.03

XRP/USD

0.39 Price
-0.050% 1D Chg, %
Long position overnight fee -0.0500%
Short position overnight fee 0.0140%
Overnight fee time 22:00 (UTC)
Spread 0.00366

Still looking for a broker you can trust?

Join the 475.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading